Margin expands as costs fall faster than revenue at Vineet Laboratories
Net profit rose 23.77% QoQ, but the increase was aided by a tax credit and other income equal to 13.92% of pre-tax profit.
Filed 26 Oct 2026, 18:34 IST · after market close · Vineet Laboratories Ltd (VINEETLAB)
Key takeaways
- Standalone operating margin rose 8.45 percentage points QoQ to 21.66% as expenses fell 50.37%, faster than revenue's 45.00% decline.
- Net profit increased 23.77% QoQ to Rs 1.51 cr despite profit before tax falling 20.20%, helped by a tax credit that produced a -92.73% tax rate.
- Vineet Laboratories' 21.66% operating margin was 1.34 percentage points above the 20.32% median for 114 Healthcare peers that had reported.
Price around the results
Revenue fell sharply, but operating margin improved
Standalone revenue declined 45.00% QoQ to Rs 10.39 cr, while operating profit fell a smaller 9.64% to Rs 2.25 cr. Expenses dropped 50.37%, allowing operating margin to expand 8.45 percentage points to 21.66%. With only the immediately preceding quarter in the available trend, the result shows a clear sequential margin improvement from 13.21%.
Tax credit drove the rise in net profit
Profit before tax declined 20.20% QoQ to Rs 0.79 cr, while net profit rose 23.77% to Rs 1.51 cr. The tax line was a Rs 0.73 cr credit, taking the tax rate to -92.73% from 27.09% in Q4FY26. Other income accounted for 13.92% of pre-tax profit, so reported net profit was not driven by operating improvement alone.
Margin was above the reported Healthcare peer median
Vineet Laboratories' 21.66% operating margin was 1.34 percentage points above the 20.32% median among 114 Healthcare peers that had reported the same quarter. The company filed these standalone results after market close on 26 October 2026, so there is no market reaction to assess yet.
Q1FY27 at a glance
Standalone figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q1FY27 | Q4FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹10 cr | ₹19 cr | -45.00% |
| Other income | ₹0 cr | ₹0 cr | +266.67% |
| Expenses | ₹8 cr | ₹16 cr | -50.37% |
| Operating profit | ₹2 cr | ₹2 cr | -9.64% |
| Operating margin (%) | 21.66% | 13.21% | — |
| Interest | ₹1 cr | ₹1 cr | -2.02% |
| Depreciation | ₹1 cr | ₹1 cr | +11.11% |
| Profit before tax | ₹1 cr | ₹1 cr | -20.20% |
| Tax | ₹-1 cr | ₹0 cr | — |
| Net profit | ₹2 cr | ₹1 cr | +23.77% |
| EPS (₹) | ₹0.73 | ₹0.43 | +69.77% |
Operating margin of 21.66% compares with a Healthcare sector median of 20.32% across 114 peers that have reported Q1FY27.
What to watch
- Whether revenue recovers from Rs 10.39 cr after the 45.00% QoQ decline.
- Whether operating margin holds above 21.66% after the 8.45-percentage-point sequential expansion.
- Whether the tax rate moves away from -92.73% and net profit remains aligned with pre-tax profit.